Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-05-18 | Dec-31-17 | Dec-31-16 |
| Revenues | 21,161.0 | 19,363.0 | 17,565.0 | 18,317.0 | 23,306.0 | 23,306.0 | 21,743.0 | 19,495.0 |
| Revenue growth | 9.3% | 10.2% | -4.1% | -21.4% | 7.2% | | 11.5% | -5.7% |
| Cost of goods sold | 15,143.0 | 13,971.0 | 12,475.0 | 12,802.0 | 15,726.0 | 15,555.0 | 14,971.0 | 13,573.0 |
| Gross profit | 6,018.0 | 5,392.0 | 5,090.0 | 5,515.0 | 7,580.0 | 7,751.0 | 6,772.0 | 5,922.0 |
| Gross margin | 28.4% | 27.8% | 29.0% | 30.1% | 32.5% | 33.3% | 31.1% | 30.4% |
| Selling, general and administrative | 3,224.0 | 2,829.0 | 2,640.0 | 2,699.0 | 3,290.0 | 3,461.0 | 3,055.0 | 2,695.0 |
| General and administrative | 148.0 | | | | | 171.0 | | |
| EBITA | 1,925.0 | 2,355.0 | 2,162.0 | 2,501.0 | 3,299.0 | 2,346.0 | 2,709.0 | 2,175.0 |
| EBITA margin | 9.1% | 12.2% | 12.3% | 13.7% | 14.2% | 10.1% | 12.5% | 11.2% |
| Amortization of intangibles | | 44.0 | 45.0 | 45.0 | 59.0 | | 77.0 | 54.0 |
| EBIT | 1,925.0 | 2,311.0 | 2,117.0 | 2,456.0 | 3,240.0 | 2,346.0 | 2,632.0 | 2,121.0 |
| EBIT margin | 9.1% | 11.9% | 12.1% | 13.4% | 13.9% | 10.1% | 12.1% | 10.9% |
| Pre-tax income | 1,511.0 | 999.0 | 329.0 | 921.0 | 1,781.0 | 1,781.0 | 848.0 | 795.0 |
| Income taxes | -236.0 | 188.0 | 176.0 | 477.0 | 445.0 | 445.0 | -1,085.0 | 193.0 |
| Tax rate | | 18.8% | 53.5% | 51.8% | 25.0% | 25.0% | | 24.3% |
| Earnings from continuing ops | 1,741.0 | 1,752.0 | 482.0 | 1,225.0 | 2,012.0 | 1,667.0 | 2,144.0 | 904.0 |
| Earnings from discontinued ops | -237.0 | 0.0 | 0.0 | | | 345.0 | | |
| Net income | 1,504.0 | 1,752.0 | 482.0 | 1,225.0 | 2,012.0 | 2,012.0 | 2,144.0 | 904.0 |
| Net margin | 7.1% | 9.0% | 2.7% | 6.7% | 8.6% | 8.6% | 9.9% | 4.6% |
| |
| Diluted EPS | $4.74 | $4.46 | $1.22 | $3.07 | $4.86 | $4.02 | $5.13 | $2.18 |
| Shares outstanding (diluted) | 367.0 | 392.4 | 395.7 | 398.8 | 414.2 | 414.2 | 417.7 | 415.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|